UPLOAD Filing
Dogwood Therapeutics, Inc.
Date: May 28, 2025 · CIK: 0001818844 · Accession: 0000000000-25-005632
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287575
Letter
Re: Dogwood Therapeutics, Inc. Registration Statement on Form S-3 Filed May 23, 2025 File No. 333-287575 Dear Greg Duncan:
May 28, 2025
Greg Duncan Chief Executive Officer Dogwood Therapeutics, Inc. 44 Milton Avenue Alpharetta, GA 30009
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Darrick M. Mix, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 28, 2025 Greg Duncan Chief Executive Officer Dogwood Therapeutics, Inc. 44 Milton Avenue Alpharetta, GA 30009 Re: Dogwood Therapeutics, Inc. Registration Statement on Form S-3 Filed May 23, 2025 File No. 333-287575 Dear Greg Duncan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Darrick M. Mix, Esq. </TEXT> </DOCUMENT>